If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

Keith Westby Biography and Net Worth

COO of IVERIC bio

Keith Westby is Senior Vice President and Chief Operating Officer of Iveric Bio. Mr. Westby joined the Company in 2007 and has over 20 years of experience in program and strategic alliance management and manufacturing operations in biotechnology companies. Mr. Westby was most recently Senior Vice President, Development Operations. Prior to joining the Company, Mr. Westby worked at Pharmasset, Inc., as Director, Project and Alliance Management. He also served in positions of increasing responsibility at Eyetech Pharmaceuticals, including Director, Alliance & Project Management, leading multifunctional project teams in the New Drug Application filing and marketing approval of Macugen. Previously, Mr. Westby worked at Tunnell Consulting, where he was a Senior Consultant in the firm’s Life Sciences practice focused on manufacturing operations and process improvement. Mr. Westby holds a BS in applied physics from the State University of New York, College at Geneseo, a MS in engineering management from Drexel University, and a MBA degree from Columbia Business School.

What is Keith Westby's net worth?: The estimated net worth of Keith Westby is at least $1.54 million as of June 2nd, 2023. Mr. Westby owns 39,652 shares of IVERIC bio stock worth more than $1,538,498 as of June 7th. This net worth evaluation does not reflect any other assets that Mr. Westby may own. Learn More about Keith Westby's net worth.
How do I contact Keith Westby?: The corporate mailing address for Mr. Westby and other IVERIC bio executives is ONE PENN PLAZA 35TH FLOOR, NEW YORK NY, 10119. IVERIC bio can also be reached via phone at (609) 474-6755 and via email at [email protected]. Learn More on Keith Westby's contact information.
Has Keith Westby been buying or selling shares of IVERIC bio?: Over the course of the past ninety days, Keith Westby has sold $3,169,114.74 of IVERIC bio stock. Most recently, Keith Westby sold 20,000 shares of the business's stock in a transaction on Friday, June 2nd. The shares were sold at an average price of $37.87, for a transaction totalling $757,400.00. Following the completion of the sale, the chief operating officer now directly owns 39,652 shares of the company's stock, valued at $1,501,621.24. Learn More on Keith Westby's trading history.
Who are IVERIC bio's active insiders?: IVERIC bio's insider roster includes David Carroll (CFO), Pravin Dugel (EVP), Glenn Sblendorio (CEO), Christopher Simms (SVP), and Keith Westby (COO). Learn More on IVERIC bio's active insiders.
Are insiders buying or selling shares of IVERIC bio?: During the last year, IVERIC bio insiders bought shares 1 times. They purchased a total of 25,000 shares worth more than $240,500.00. During the last year, insiders at the sold shares 24 times. They sold a total of 469,613 shares worth more than $12,642,059.69. The most recent insider tranaction occured on June, 2nd when COO Keith Westby sold 20,000 shares worth more than $757,400.00. Insiders at IVERIC bio own 2.9% of the company. Learn More about insider trades at IVERIC bio.
Information on this page was last updated on 6/2/2023.

Keith Westby Insider Trading History at IVERIC bio

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/2/2023	Sell	20,000	$37.87	$757,400.00	39,652
5/1/2023	Sell	20,000	$37.12	$742,400.00	39,652
4/24/2023	Sell	18,782	$30.07	$564,774.74	39,652
4/21/2023	Sell	1,218	$30.00	$36,540.00	39,652
4/3/2023	Sell	40,000	$26.70	$1,068,000.00	39,652
3/2/2023	Sell	20,000	$23.93	$478,600.00	39,652
2/17/2023	Sell	15,000	$25.05	$375,750.00	46,354
1/3/2023	Sell	3,480	$20.06	$69,808.80	86,354
12/19/2022	Sell	6,740	$21.51	$144,977.40	81,084
12/12/2022	Sell	5,393	$20.89	$112,659.77	69,565
12/1/2022	Sell	10,030	$22.96	$230,288.80	59,759
11/1/2022	Sell	72,916	$23.92	$1,744,150.72	69,128
4/18/2022	Sell	10,000	$16.63	$166,300.00	99,128
4/5/2022	Sell	9,298	$19.02	$176,847.96	109,128
2/7/2022	Sell	10,000	$15.00	$150,000.00
1/3/2022	Sell	12,278	$16.39	$201,236.42
12/20/2021	Sell	4,516	$15.44	$69,727.04
12/13/2021	Sell	4,517	$14.74	$66,580.58
12/10/2021	Sell	3,614	$14.53	$52,511.42
12/10/2020	Sell	3,676	$6.96	$25,584.96
1/6/2020	Sell	293	$8.07	$2,364.51	41,276
12/13/2019	Sell	4,530	$6.60	$29,898.00	45,106

Keith Westby Buying and Selling Activity at IVERIC bio

IVERIC bio Company Overview

IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ.

Today's Range

Now: $38.80

$38.60

$38.96

50 Day Range

MA: $33.34

$23.77

$38.90

2 Week Range

Now: $38.80

$8.85

$38.99

Volume

3,608,180 shs

Average Volume

3,204,329 shs

Market Capitalization

$5.35 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.1

The Safest Option in Trades!

From Tradewins | Ad

Click here now!